With a r/s adjusted 4M float?
I play bio's, I watch them crash when they don't meet FDA approval, I like to bottom fish them.
There's bio's trading for twice or three times the price of DSCO after crashing and have nothing else in their pipeline beyond some pre clinical studies.
It's beyond me how this bio with a drug in their pipeline in Phase II s trading at 79 cents now?
Absolutely hilarious !!